CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 24 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 2,631.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $1,033,000 | – | 350,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,077,465 | $3,179,000 | 0.56% |
| DAFNA Capital Management LLC | 44,300 | $131,000 | 0.19% |
| Perceptive Advisors | 350,000 | $1,033,000 | 0.10% |
| Catalyst Capital Advisors LLC | 43,000 | $127,000 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 73,895 | $218,000 | 0.09% |
| Invesco Private Capital | 116,316 | $343,000 | 0.04% |
| Allianz Asset Management GmbH | 559,207 | $1,650,000 | 0.00% |
| A.R.T. Advisors, LLC | 19,507 | $57,000 | 0.00% |
| BARCLAYS PLC | 230,000 | $679,000 | 0.00% |
| KNIGHT CAPITAL GROUP LLC | 26,263 | $77,000 | 0.00% |